Clinical Trial Update: Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma [Phase 2]

View source ↗

Summary

Phase 2 trial of antineoplaston therapy in children with recurrent or refractory high-grade glioma was terminated, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Glioma

Drugs mentioned

• Antineoplaston therapy

Snippet

Sponsor: Burzynski Research Institute | Conditions: High Grade Glioma | Phase 2 | Status: TERMINATED | Results posted: 2017-12-13